US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

IO Biotech, Inc.

1.80

-0.0050-0.28%

Volume:378.32K

Turnover:672.71K

Market Cap:118.26M

PE:-1.14

High:1.82

Open:1.77

Low:1.71

Close:1.80

52wk High:2.79

52wk Low:0.6600

Shares:65.88M

Float Shares:31.28M

Volume Ratio:0.62

T/O Rate:1.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.5784

EPS(LYR):-1.4494

ROE:-212.51%

ROA:-80.63%

PB:74.28

PE(LYR):-1.24

Loading ...

Overview Company News Filings

IO Biotech Inc : Jefferies Cuts Target Price to $4 From $8

THOMSON REUTERS

IO Biotech Announces Participation in Upcoming Investor Conferences

IO Biotech Inc reports results for the quarter ended June 30 - Earnings Summary

IO Biotech Q2 EPS $(0.40) Misses $(0.35) Estimate

IO Biotech Q2 Pretax Profit USD -26.099 Million

THOMSON REUTERS

IO Biotech Inc - Expects That Co Will Have Sufficient Cash to Run Company Into Q1 of 2026

THOMSON REUTERS

IO Biotech Reports Second Quarter 2025 Financial Results and Provides Business Highlights

IO Biotech Inc expected to post a loss of 36 cents a share - Earnings Preview

BUZZ-U.S. STOCKS ON THE MOVE-Elf Beauty, Intel, Archer Aviation

BUZZ-IO Biotech drops after cancer vaccine narrowly misses main goal of late-stage study

IO Biotech Shares up 12.2% at $2.03 Premarket in Volatile Trading Shortly After Trading Halt

THOMSON REUTERS

IO Biotech Shares up 56.9% Premarket After Co Reports Late-Stage Data for Therapeutic Cancer Vaccine

THOMSON REUTERS

IO Biotech Announces Promising Results in Phase 3 Trial of Cylembio Plus KEYTRUDA for Advanced Melanoma, Plans FDA Meeting

IO Biotech Inc - Cylembio Plus Keytruda Well Tolerated With No New Safety Signals

THOMSON REUTERS

IO Biotech Inc - Plans FDA Meeting This Fall for Regulatory Submission

THOMSON REUTERS

IO Biotech Announces Clinical Improvement in Progression Free Survival Demonstrated in Pivotal Phase 3 Trial of Cylembio® Plus Keytruda® (Pembrolizumab) for the Treatment of First-Line Advanced Melanoma, but Statistical Significance Narrowly Missed

THOMSON REUTERS

IO Biotech to Announce Topline Results of Pivotal Phase 3 Trial of Cylembio® in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma

Calendar of U.S. Earnings Expected in the Week Ahead

IO Biotech Inc expected to post a loss of 36 cents a share - Earnings Preview

BRIEF-IO Biotech Files Prospectus Relates To Resale, From Time To Time For Offering Of Up To 4.2 Million Shares By Selling Stockholders- SEC Filing

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IOBT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IOBT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IOBT\",,,,,undefined,":{"symbol":"IOBT","market":"US","secType":"STK","nameCN":"IO Biotech, Inc.","latestPrice":1.795,"timestamp":1757434184460,"preClose":1.8,"halted":0,"volume":378321,"delay":0,"floatShares":31282748,"shares":65880914,"eps":-1.578393,"marketStatus":"Trading","change":-0.005,"latestTime":"09-09 12:13:51 EDT","open":1.77,"high":1.82,"low":1.71,"amount":672710.3133549,"amplitude":0.061111,"askPrice":1.8,"askSize":200,"bidPrice":1.79,"bidSize":17200,"shortable":3,"etf":0,"ttmEps":-1.578393,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1757448000000},"marketStatusCode":2,"adr":0,"listingDate":1636084800000,"exchange":"NASDAQ","adjPreClose":1.8,"preHourTrading":{"tag":"盘前","latestPrice":1.7714,"preClose":1.8,"latestTime":"09:23 EDT","volume":8916,"amount":16021.659696,"timestamp":1757424209463},"postHourTrading":{"tag":"盘后","latestPrice":1.8,"preClose":1.8,"latestTime":"19:44 EDT","volume":15192,"amount":27269.2423,"timestamp":1757375068643},"volumeRatio":0.615732},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IOBT\",,,,,undefined,":{"symbol":"IOBT","floatShares":31282748,"roa":"-80.63%","roe":"-212.51%","lyrEps":-1.449448,"volumeRatio":0.615732,"shares":65880914,"dividePrice":0,"high":1.82,"amplitude":0.061111,"preClose":1.8,"low":1.71,"week52Low":0.66,"pbRate":"74.28","week52High":2.79,"institutionHeld":0,"latestPrice":1.795,"committee":0.977011,"eps":-1.578393,"divideRate":0,"volume":378321,"delay":0,"ttmEps":-1.578393,"open":1.77,"prevYearClose":0.92,"prevWeekClose":1.95,"prevMonthClose":1.58,"prevQuarterClose":1.39,"fiveDayClose":1.67,"twentyDayClose":1.05,"sixtyDayClose":1.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IOBT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-14","symbol":"IOBT","fiscalQuarterEnding":"2025/06","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.4},{"market":"US","date":"2025-05-14","symbol":"IOBT","fiscalQuarterEnding":"2025/03","expectedEps":-0.45,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"pre","actualEps":-0.34}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IOBT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IOBT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.6667,"hold":0,"sell":0,"strongSell":0.1667,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1734753600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IOBT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IOBT","date":"2025-09-08","current":-1.235433,"percent":0.373932,"low":-8.362196,"twenty":-1.639198,"median":-1.08338,"eighty":-0.765906,"high":-0.497352,"avg":-1.516483,"sd":1.287638,"marketCap":128467782},"quantilePoints":[{"date":"2021-11-05","current":-8.362196,"twenty":-8.009541,"median":-7.480559,"eighty":-7.480559,"marketCap":402631368},{"date":"2021-11-12","current":-6.882294,"twenty":-7.813632,"median":-7.480559,"eighty":-7.246158,"marketCap":331375570},{"date":"2021-11-19","current":-5.21259,"twenty":-7.538329,"median":-7.229401,"eighty":-6.446615,"marketCap":250980975},{"date":"2021-11-26","current":-4.554283,"twenty":-7.480559,"median":-6.702756,"eighty":-4.748184,"marketCap":219284181},{"date":"2021-12-03","current":-6.523218,"twenty":-7.438706,"median":-6.415495,"eighty":-4.69552,"marketCap":314086410},{"date":"2021-12-10","current":-6.313757,"twenty":-7.262915,"median":-6.313757,"eighty":-5.001932,"marketCap":304001066},{"date":"2021-12-17","current":-5.865823,"twenty":-7.15998,"median":-6.232964,"eighty":-5.216181,"marketCap":288152670},{"date":"2021-12-23","current":-4.839304,"twenty":-6.882294,"median":-6.068388,"eighty":-4.845169,"marketCap":237725952},{"date":"2021-12-31","current":-3.754126,"twenty":-6.702756,"median":-6.002557,"eighty":-4.632083,"marketCap":184417708},{"date":"2022-01-07","current":-4.065015,"twenty":-6.654879,"median":-5.730714,"eighty":-4.293782,"marketCap":199689800},{"date":"2022-01-14","current":-4.458025,"twenty":-6.523218,"median":-5.230543,"eighty":-4.249068,"marketCap":218996029},{"date":"2022-01-21","current":-3.757059,"twenty":-6.49928,"median":-4.949267,"eighty":-4.217538,"marketCap":184561785},{"date":"2022-01-28","current":-4.56361,"twenty":-6.373603,"median":-4.792377,"eighty":-4.181159,"marketCap":224182777},{"date":"2022-02-04","current":-4.77478,"twenty":-6.319742,"median":-4.77478,"eighty":-4.191764,"marketCap":234556273},{"date":"2022-02-11","current":-5.02701,"twenty":-6.308969,"median":-4.842237,"eighty":-4.217538,"marketCap":246946838},{"date":"2022-02-18","current":-4.985949,"twenty":-6.274258,"median":-4.880364,"eighty":-4.223392,"marketCap":244929769},{"date":"2022-02-25","current":-4.293782,"twenty":-6.226381,"median":-4.868633,"eighty":-4.223392,"marketCap":210927754},{"date":"2022-03-04","current":-3.619213,"twenty":-6.124643,"median":-4.815841,"eighty":-4.179986,"marketCap":177790197},{"date":"2022-03-11","current":-2.229013,"twenty":-6.067191,"median":-4.74545,"eighty":-4.127193,"marketCap":109498014},{"date":"2022-03-18","current":-2.328732,"twenty":-6.051631,"median":-4.669194,"eighty":-4.041552,"marketCap":114396609},{"date":"2022-03-25","current":-2.99157,"twenty":-6.019314,"median":-4.632083,"eighty":-3.853845,"marketCap":146957861},{"date":"2022-04-01","current":-2.406968,"twenty":-5.920517,"median":-4.558946,"eighty":-3.650888,"marketCap":163382563},{"date":"2022-04-08","current":-3.476731,"twenty":-5.865823,"median":-4.411099,"eighty":-3.379544,"marketCap":235997036},{"date":"2022-04-14","current":-3.052222,"twenty":-5.757735,"median":-4.293782,"eighty":-3.177027,"marketCap":207181769},{"date":"2022-04-22","current":-3.557388,"twenty":-5.590816,"median":-4.287916,"eighty":-3.161745,"marketCap":241471937},{"date":"2022-04-29","current":-3.077692,"twenty":-5.442398,"median":-4.249068,"eighty":-3.148161,"marketCap":208910685},{"date":"2022-05-06","current":-3.18382,"twenty":-5.223362,"median":-4.217526,"eighty":-3.136275,"marketCap":216114502},{"date":"2022-05-13","current":-3.196555,"twenty":-5.178246,"median":-4.182332,"eighty":-3.107832,"marketCap":216978960},{"date":"2022-05-20","current":-1.785565,"twenty":-5.112651,"median":-4.158868,"eighty":-3.076312,"marketCap":145228945},{"date":"2022-05-27","current":-1.611969,"twenty":-5.084495,"median":-4.106076,"eighty":-3.043189,"marketCap":131109464},{"date":"2022-06-03","current":-1.806822,"twenty":-5.064552,"median":-4.065015,"eighty":-2.850838,"marketCap":146957861},{"date":"2022-06-10","current":-1.647396,"twenty":-5.024664,"median":-4.003424,"eighty":-2.469511,"marketCap":133990991},{"date":"2022-06-17","current":-1.367516,"twenty":-5.012932,"median":-3.918369,"eighty":-2.352195,"marketCap":111226930},{"date":"2022-06-24","current":-1.711167,"twenty":-5.003547,"median":-3.754126,"eighty":-2.293537,"marketCap":139177739},{"date":"2022-07-01","current":-1.594255,"twenty":-4.997681,"median":-3.645609,"eighty":-2.229013,"marketCap":129668701},{"date":"2022-07-08","current":-1.718252,"twenty":-4.997681,"median":-3.557388,"eighty":-1.937905,"marketCap":139754044},{"date":"2022-07-15","current":-1.487971,"twenty":-4.988295,"median":-3.476731,"eighty":-1.820993,"marketCap":121024121},{"date":"2022-07-22","current":-1.516313,"twenty":-4.956603,"median":-3.36586,"eighty":-1.774937,"marketCap":123329342},{"date":"2022-07-29","current":-1.371059,"twenty":-4.936379,"median":-3.264179,"eighty":-1.717543,"marketCap":111515083},{"date":"2022-08-05","current":-1.459629,"twenty":-4.890923,"median":-3.210351,"eighty":-1.711167,"marketCap":118718900},{"date":"2022-08-12","current":-1.846922,"twenty":-4.870979,"median":-3.18382,"eighty":-1.705498,"marketCap":113532151},{"date":"2022-08-19","current":-1.664105,"twenty":-4.849862,"median":-3.171085,"eighty":-1.705498,"marketCap":102294197},{"date":"2022-08-26","current":-1.743795,"twenty":-4.840477,"median":-3.149859,"eighty":-1.691327,"marketCap":107192793},{"date":"2022-09-02","current":-1.509414,"twenty":-4.801762,"median":-3.128634,"eighty":-1.66223,"marketCap":92785159},{"date":"2022-09-09","current":-1.415661,"twenty":-4.781819,"median":-3.093612,"eighty":-1.651648,"marketCap":87022106},{"date":"2022-09-16","current":-1.469569,"twenty":-4.757182,"median":-3.077692,"eighty":-1.636768,"marketCap":90335862},{"date":"2022-09-23","current":-1.204718,"twenty":-4.741931,"median":-3.062835,"eighty":-1.612312,"marketCap":74055236},{"date":"2022-09-30","current":-1.270345,"twenty":-4.707909,"median":-3.038496,"eighty":-1.594255,"marketCap":78089373},{"date":"2022-10-07","current":-1.195343,"twenty":-4.665675,"median":-2.892613,"eighty":-1.555888,"marketCap":73478930},{"date":"2022-10-14","current":-1.115653,"twenty":-4.644558,"median":-2.52817,"eighty":-1.50934,"marketCap":68580335},{"date":"2022-10-21","current":-1.096903,"twenty":-4.635196,"median":-2.453475,"eighty":-1.474233,"marketCap":67427724},{"date":"2022-10-28","current":-1.129716,"twenty":-4.61772,"median":-2.375658,"eighty":-1.444696,"marketCap":69444793},{"date":"2022-11-04","current":-1.078153,"twenty":-4.581424,"median":-2.325799,"eighty":-1.427515,"marketCap":66275114},{"date":"2022-11-11","current":-1.182006,"twenty":-4.558014,"median":-2.252476,"eighty":-1.410974,"marketCap":85927126},{"date":"2022-11-18","current":-1.145539,"twenty":-4.496528,"median":-2.229013,"eighty":-1.403532,"marketCap":83276121},{"date":"2022-11-25","current":-1.070227,"twenty":-4.439255,"median":-2.188697,"eighty":-1.374602,"marketCap":77801220},{"date":"2022-12-02","current":-1.169322,"twenty":-4.394163,"median":-1.898486,"eighty":-1.367516,"marketCap":85005037},{"date":"2022-12-09","current":-1.105901,"twenty":-4.338769,"median":-1.885792,"eighty":-1.344134,"marketCap":80394594},{"date":"2022-12-16","current":-1.070227,"twenty":-4.293782,"median":-1.846922,"eighty":-1.290033,"marketCap":77801220},{"date":"2022-12-23","current":-1.050408,"twenty":-4.291436,"median":-1.815679,"eighty":-1.228405,"marketCap":76360457},{"date":"2022-12-30","current":-0.911675,"twenty":-4.287916,"median":-1.785565,"eighty":-1.200968,"marketCap":66275114},{"date":"2023-01-06","current":-0.990951,"twenty":-4.287916,"median":-1.778116,"eighty":-1.195343,"marketCap":72038167},{"date":"2023-01-13","current":-0.92753,"twenty":-4.276185,"median":-1.743795,"eighty":-1.17725,"marketCap":67427724},{"date":"2023-01-20","current":-1.169322,"twenty":-4.254491,"median":-1.725044,"eighty":-1.171905,"marketCap":85005037},{"date":"2023-01-27","current":-1.117793,"twenty":-4.228527,"median":-1.718252,"eighty":-1.169322,"marketCap":81259052},{"date":"2023-02-03","current":-1.070227,"twenty":-4.223392,"median":-1.714709,"eighty":-1.164792,"marketCap":77801220},{"date":"2023-02-10","current":-1.054372,"twenty":-4.214007,"median":-1.711167,"eighty":-1.156967,"marketCap":76648610},{"date":"2023-02-17","current":-1.038517,"twenty":-4.19763,"median":-1.701606,"eighty":-1.145539,"marketCap":75495999},{"date":"2023-02-24","current":-0.998879,"twenty":-4.187048,"median":-1.693453,"eighty":-1.134454,"marketCap":72614472},{"date":"2023-03-03","current":-1.038517,"twenty":-4.178812,"median":-1.664608,"eighty":-1.114923,"marketCap":75495999},{"date":"2023-03-10","current":-0.986987,"twenty":-4.169427,"median":-1.654482,"eighty":-1.106127,"marketCap":71750014},{"date":"2023-03-17","current":-0.79843,"twenty":-4.157695,"median":-1.647396,"eighty":-1.101937,"marketCap":57054228},{"date":"2023-03-24","current":-0.806495,"twenty":-4.145963,"median":-1.636768,"eighty":-1.096903,"marketCap":57630534},{"date":"2023-03-31","current":-0.756089,"twenty":-4.120154,"median":-1.627571,"eighty":-1.089039,"marketCap":54028625},{"date":"2023-04-06","current":-0.750041,"twenty":-4.096691,"median":-1.612255,"eighty":-1.078154,"marketCap":53596396},{"date":"2023-04-14","current":-0.745564,"twenty":-4.075574,"median":-1.607854,"eighty":-1.070227,"marketCap":53276547},{"date":"2023-04-21","current":-0.774235,"twenty":-4.05563,"median":-1.587169,"eighty":-1.062299,"marketCap":55325312},{"date":"2023-04-28","current":-0.762138,"twenty":-4.041552,"median":-1.55629,"eighty":-1.051994,"marketCap":54460854},{"date":"2023-05-05","current":-0.838755,"twenty":-4.01105,"median":-1.526926,"eighty":-1.042969,"marketCap":59935755},{"date":"2023-05-12","current":-0.868928,"twenty":-3.946525,"median":-1.509228,"eighty":-1.038517,"marketCap":61952824},{"date":"2023-05-19","current":-0.792139,"twenty":-3.918369,"median":-1.482657,"eighty":-1.030589,"marketCap":56477923},{"date":"2023-05-26","current":-0.812347,"twenty":-3.853845,"median":-1.459629,"eighty":-1.024247,"marketCap":57918686},{"date":"2023-06-02","current":-0.808305,"twenty":-3.756472,"median":-1.448428,"eighty":-1.014734,"marketCap":57630534},{"date":"2023-06-09","current":-0.838616,"twenty":-3.75178,"median":-1.432849,"eighty":-1.007599,"marketCap":59791679},{"date":"2023-06-16","current":-0.828513,"twenty":-3.728317,"median":-1.424201,"eighty":-1.002842,"marketCap":59071297},{"date":"2023-06-23","current":-0.763848,"twenty":-3.672005,"median":-1.415661,"eighty":-0.994915,"marketCap":54460854},{"date":"2023-06-30","current":-0.775973,"twenty":-3.629771,"median":-1.410974,"eighty":-0.986374,"marketCap":55325312},{"date":"2023-07-07","current":-0.739559,"twenty":-3.582118,"median":-1.406286,"eighty":-0.971132,"marketCap":52729057},{"date":"2023-07-14","current":-0.727475,"twenty":-3.557388,"median":-1.397629,"eighty":-0.943369,"marketCap":51867480},{"date":"2023-07-21","current":-0.759807,"twenty":-3.519182,"median":-1.374602,"eighty":-0.886566,"marketCap":54172701},{"date":"2023-07-28","current":-0.775973,"twenty":-3.483523,"median":-1.369287,"eighty":-0.858917,"marketCap":55325312},{"date":"2023-08-04","current":-0.755765,"twenty":-3.42579,"median":-1.360431,"eighty":-0.838699,"marketCap":53884549},{"date":"2023-08-11","current":-0.739599,"twenty":-3.379094,"median":-1.344488,"eighty":-0.829434,"marketCap":52731938},{"date":"2023-08-18","current":-1.727592,"twenty":-3.364911,"median":-1.360431,"eighty":-0.831552,"marketCap":127808973},{"date":"2023-08-25","current":-1.718687,"twenty":-3.346432,"median":-1.369287,"eighty":-0.834979,"marketCap":127150164},{"date":"2023-09-01","current":-1.638541,"twenty":-3.293165,"median":-1.374602,"eighty":-0.837808,"marketCap":121220881},{"date":"2023-09-08","current":-1.53346,"twenty":-3.249016,"median":-1.395858,"eighty":-0.838672,"marketCap":113446933},{"date":"2023-09-15","current":-1.309052,"twenty":-3.222026,"median":-1.38523,"eighty":-0.839508,"marketCap":96844943},{"date":"2023-09-22","current":-1.255621,"twenty":-3.211413,"median":-1.373473,"eighty":-0.840637,"marketCap":92892088},{"date":"2023-09-29","current":-1.18438,"twenty":-3.201649,"median":-1.367516,"eighty":-0.84311,"marketCap":87621615},{"date":"2023-10-06","current":-1.282336,"twenty":-3.191461,"median":-1.35941,"eighty":-0.854885,"marketCap":94868516},{"date":"2023-10-13","current":-1.032993,"twenty":-3.18382,"median":-1.343695,"eighty":-0.867744,"marketCap":76421860},{"date":"2023-10-20","current":-0.935037,"twenty":-3.180424,"median":-1.331284,"eighty":-0.868904,"marketCap":69174959},{"date":"2023-10-27","current":-0.80146,"twenty":-3.177028,"median":-1.317957,"eighty":-0.868507,"marketCap":59292822},{"date":"2023-11-03","current":-0.79398,"twenty":-3.168537,"median":-1.309052,"eighty":-0.840261,"marketCap":58739422},{"date":"2023-11-10","current":-0.83806,"twenty":-3.160047,"median":-1.282336,"eighty":-0.838505,"marketCap":62000528},{"date":"2023-11-17","current":-0.790436,"twenty":-3.151557,"median":-1.267435,"eighty":-0.831257,"marketCap":63212736},{"date":"2023-11-24","current":-0.963846,"twenty":-3.144765,"median":-1.260074,"eighty":-0.829434,"marketCap":77080669},{"date":"2023-12-01","current":-0.963846,"twenty":-3.136275,"median":-1.255621,"eighty":-0.830955,"marketCap":77080669},{"date":"2023-12-08","current":-1.079178,"twenty":-3.127784,"median":-1.242263,"eighty":-0.831846,"marketCap":86303997},{"date":"2023-12-15","current":-1.078436,"twenty":-3.113351,"median":-1.233295,"eighty":-0.832244,"marketCap":86244704},{"date":"2023-12-22","current":-1.202748,"twenty":-3.096795,"median":-1.228779,"eighty":-0.832554,"marketCap":96186134},{"date":"2023-12-29","current":-1.60641,"twenty":-3.092975,"median":-1.236756,"eighty":-0.834979,"marketCap":128467782},{"date":"2024-01-05","current":-1.589934,"twenty":-3.090428,"median":-1.237811,"eighty":-0.836889,"marketCap":127150164},{"date":"2024-01-12","current":-1.56522,"twenty":-3.087881,"median":-1.249155,"eighty":-0.838171,"marketCap":125173736},{"date":"2024-01-19","current":-1.48284,"twenty":-3.077692,"median":-1.255621,"eighty":-0.838616,"marketCap":118585645},{"date":"2024-01-26","current":-1.507554,"twenty":-3.075392,"median":-1.264526,"eighty":-0.838755,"marketCap":120562072},{"date":"2024-02-02","current":-1.48284,"twenty":-3.073447,"median":-1.272689,"eighty":-0.840637,"marketCap":118585645},{"date":"2024-02-09","current":-1.52403,"twenty":-3.052222,"median":-1.291241,"eighty":-0.840637,"marketCap":121879690},{"date":"2024-02-16","current":-1.252176,"twenty":-3.050228,"median":-1.309052,"eighty":-0.844561,"marketCap":100138989},{"date":"2024-02-23","current":-1.219224,"twenty":-3.040842,"median":-1.300147,"eighty":-0.846368,"marketCap":97503752},{"date":"2024-03-01","current":-1.31808,"twenty":-3.000955,"median":-1.291241,"eighty":-0.86295,"marketCap":105409462},{"date":"2024-03-08","current":-1.354614,"twenty":-2.968106,"median":-1.300147,"eighty":-0.867995,"marketCap":116609217},{"date":"2024-03-15","current":-1.301041,"twenty":-2.850838,"median":-1.309052,"eighty":-0.86876,"marketCap":111997553},{"date":"2024-03-22","current":-1.239816,"twenty":-2.816195,"median":-1.296141,"eighty":-0.86892,"marketCap":106727080},{"date":"2024-03-28","current":-1.324001,"twenty":-2.642701,"median":-1.304868,"eighty":-0.878628,"marketCap":113973981},{"date":"2024-04-05","current":-1.255122,"twenty":-2.492975,"median":-1.308695,"eighty":-0.886566,"marketCap":108044698},{"date":"2024-04-12","current":-1.22451,"twenty":-2.469511,"median":-1.296141,"eighty":-0.899403,"marketCap":105409462},{"date":"2024-04-19","current":-1.125018,"twenty":-2.450267,"median":-1.285128,"eighty":-0.909928,"marketCap":96844943},{"date":"2024-04-26","current":-1.109712,"twenty":-2.419156,"median":-1.275962,"eighty":-0.915006,"marketCap":95527325},{"date":"2024-05-03","current":-1.170937,"twenty":-2.388182,"median":-1.270345,"eighty":-0.923409,"marketCap":100797798},{"date":"2024-05-10","current":-1.209203,"twenty":-2.358061,"median":-1.263651,"eighty":-0.932034,"marketCap":104091844},{"date":"2024-05-17","current":-1.042231,"twenty":-2.335771,"median":-1.255621,"eighty":-0.94038,"marketCap":92233279},{"date":"2024-05-24","current":-0.982675,"twenty":-2.325212,"median":-1.255372,"eighty":-0.949934,"marketCap":86962806},{"date":"2024-05-31","current":-0.923119,"twenty":-2.311134,"median":-1.251885,"eighty":-0.938599,"marketCap":81692333},{"date":"2024-06-07","current":-0.930563,"twenty":-2.277113,"median":-1.246716,"eighty":-0.919584,"marketCap":82351142},{"date":"2024-06-14","current":-0.952897,"twenty":-2.251961,"median":-1.243938,"eighty":-0.91895,"marketCap":84327569},{"date":"2024-06-21","current":-0.915674,"twenty":-2.249899,"median":-1.239816,"eighty":-0.917227,"marketCap":81033524},{"date":"2024-06-28","current":-0.871007,"twenty":-2.241545,"median":-1.237811,"eighty":-0.916295,"marketCap":77080669},{"date":"2024-07-05","current":-0.841229,"twenty":-2.229013,"median":-1.2357,"eighty":-0.912475,"marketCap":74445432},{"date":"2024-07-12","current":-1.012453,"twenty":-2.221099,"median":-1.230471,"eighty":-0.907492,"marketCap":89598043},{"date":"2024-07-15","current":-0.962575,"twenty":-2.213185,"median":-1.228779,"eighty":-0.907676,"marketCap":85184021},{"date":"2024-08-02","current":-0.945452,"twenty":-2.205271,"median":-1.228468,"eighty":-0.907861,"marketCap":83668760},{"date":"2024-08-09","current":-1.072009,"twenty":-2.188548,"median":-1.22451,"eighty":-0.90823,"marketCap":94868516},{"date":"2024-08-16","current":-1.010627,"twenty":-2.044301,"median":-1.219224,"eighty":-0.910297,"marketCap":88939233},{"date":"2024-08-23","current":-1.19778,"twenty":-1.918505,"median":-1.209203,"eighty":-0.914074,"marketCap":105409462},{"date":"2024-08-30","current":-1.152864,"twenty":-1.89663,"median":-1.209203,"eighty":-0.915674,"marketCap":101456607},{"date":"2024-09-06","current":-0.670083,"twenty":-1.893975,"median":-1.206961,"eighty":-0.909608,"marketCap":58970006},{"date":"2024-09-13","current":-0.57486,"twenty":-1.887003,"median":-1.200031,"eighty":-0.896319,"marketCap":50589953},{"date":"2024-09-20","current":-0.890849,"twenty":-1.878912,"median":-1.196206,"eighty":-0.888868,"marketCap":78398287},{"date":"2024-09-27","current":-0.801016,"twenty":-1.865376,"median":-1.193105,"eighty":-0.873985,"marketCap":70492577},{"date":"2024-10-04","current":-0.756099,"twenty":-1.845047,"median":-1.187693,"eighty":-0.868904,"marketCap":66539723},{"date":"2024-10-11","current":-0.771071,"twenty":-1.835155,"median":-1.18438,"eighty":-0.863336,"marketCap":67857341},{"date":"2024-10-18","current":-0.905821,"twenty":-1.817817,"median":-1.182808,"eighty":-0.863336,"marketCap":79715905},{"date":"2024-10-25","current":-0.913308,"twenty":-1.807372,"median":-1.181213,"eighty":-0.867488,"marketCap":80374715},{"date":"2024-10-31","current":-0.958224,"twenty":-1.805224,"median":-1.178591,"eighty":-0.868277,"marketCap":84327569},{"date":"2024-11-08","current":-0.920794,"twenty":-1.796179,"median":-1.176301,"eighty":-0.868277,"marketCap":81033524},{"date":"2024-11-15","current":-0.649037,"twenty":-1.785565,"median":-1.171905,"eighty":-0.860905,"marketCap":58634013},{"date":"2024-11-22","current":-0.497352,"twenty":-1.785547,"median":-1.171905,"eighty":-0.841895,"marketCap":44930783},{"date":"2024-11-29","current":-0.649037,"twenty":-1.785475,"median":-1.170129,"eighty":-0.840637,"marketCap":58634013},{"date":"2024-12-06","current":-0.59726,"twenty":-1.781295,"median":-1.169322,"eighty":-0.83806,"marketCap":53956468},{"date":"2024-12-13","current":-0.577424,"twenty":-1.774937,"median":-1.163944,"eighty":-0.832038,"marketCap":52164507},{"date":"2024-12-20","current":-0.554307,"twenty":-1.774937,"median":-1.157842,"eighty":-0.828513,"marketCap":50076082},{"date":"2024-12-27","current":-0.6855,"twenty":-1.765557,"median":-1.155631,"eighty":-0.826658,"marketCap":61928059},{"date":"2025-01-03","current":-0.675144,"twenty":-1.751562,"median":-1.153467,"eighty":-0.823474,"marketCap":60992550},{"date":"2025-01-10","current":-0.627087,"twenty":-1.739246,"median":-1.148467,"eighty":-0.818687,"marketCap":56650997},{"date":"2025-01-17","current":-0.589967,"twenty":-1.730491,"median":-1.147978,"eighty":-0.812347,"marketCap":53297659},{"date":"2025-01-24","current":-0.65272,"twenty":-1.727082,"median":-1.145539,"eighty":-0.808305,"marketCap":58966712},{"date":"2025-01-31","current":-0.6855,"twenty":-1.724106,"median":-1.144307,"eighty":-0.808305,"marketCap":61928059},{"date":"2025-02-07","current":-0.707378,"twenty":-1.720022,"median":-1.140089,"eighty":-0.802467,"marketCap":63904486},{"date":"2025-02-14","current":-0.6855,"twenty":-1.7186,"median":-1.137612,"eighty":-0.798788,"marketCap":61928059},{"date":"2025-02-21","current":-0.809473,"twenty":-1.718252,"median":-1.132671,"eighty":-0.79843,"marketCap":73127814},{"date":"2025-02-28","current":-0.728745,"twenty":-1.718252,"median":-1.127372,"eighty":-0.792555,"marketCap":65834797},{"date":"2025-03-07","current":-0.668727,"twenty":-1.714709,"median":-1.125018,"eighty":-0.790436,"marketCap":60412798},{"date":"2025-03-14","current":-0.649037,"twenty":-1.714709,"median":-1.11908,"eighty":-0.786043,"marketCap":58634013},{"date":"2025-03-21","current":-0.692792,"twenty":-1.714709,"median":-1.117365,"eighty":-0.78261,"marketCap":62586868},{"date":"2025-03-28","current":-0.845936,"twenty":-1.711167,"median":-1.111847,"eighty":-0.7823,"marketCap":76421860},{"date":"2025-04-04","current":-0.693367,"twenty":-1.711167,"median":-1.107883,"eighty":-0.778268,"marketCap":66210318},{"date":"2025-04-11","current":-0.591811,"twenty":-1.709782,"median":-1.105901,"eighty":-0.775973,"marketCap":56512648},{"date":"2025-04-17","current":-0.614027,"twenty":-1.709782,"median":-1.101998,"eighty":-0.772585,"marketCap":58634013},{"date":"2025-04-25","current":-0.636656,"twenty":-1.708056,"median":-1.101937,"eighty":-0.76617,"marketCap":60794907},{"date":"2025-05-02","current":-0.696817,"twenty":-1.70281,"median":-1.097438,"eighty":-0.763848,"marketCap":66539723},{"date":"2025-05-09","current":-0.683018,"twenty":-1.701023,"median":-1.094405,"eighty":-0.761735,"marketCap":65222104},{"date":"2025-05-16","current":-0.68253,"twenty":-1.697771,"median":-1.092595,"eighty":-0.758138,"marketCap":67198532},{"date":"2025-05-23","current":-0.802977,"twenty":-1.694161,"median":-1.087528,"eighty":-0.757704,"marketCap":79057096},{"date":"2025-05-30","current":-0.809668,"twenty":-1.692564,"median":-1.086898,"eighty":-0.758105,"marketCap":79715905},{"date":"2025-06-06","current":-1.003721,"twenty":-1.686628,"median":-1.08505,"eighty":-0.758105,"marketCap":98821371},{"date":"2025-06-13","current":-1.003721,"twenty":-1.682921,"median":-1.078436,"eighty":-0.75813,"marketCap":98821371},{"date":"2025-06-20","current":-0.869892,"twenty":-1.679394,"median":-1.078153,"eighty":-0.75881,"marketCap":85645188},{"date":"2025-06-27","current":-0.990338,"twenty":-1.674214,"median":-1.071322,"eighty":-0.759807,"marketCap":97503752},{"date":"2025-07-03","current":-0.99703,"twenty":-1.672351,"median":-1.070227,"eighty":-0.75987,"marketCap":98162561},{"date":"2025-07-11","current":-0.936806,"twenty":-1.664909,"median":-1.070227,"eighty":-0.760525,"marketCap":92233279},{"date":"2025-07-18","current":-1.338295,"twenty":-1.66223,"median":-1.070227,"eighty":-0.762276,"marketCap":131761828},{"date":"2025-07-25","current":-1.291455,"twenty":-1.65468,"median":-1.070636,"eighty":-0.762878,"marketCap":127150164},{"date":"2025-08-01","current":-1.492199,"twenty":-1.654482,"median":-1.075081,"eighty":-0.763233,"marketCap":146914438},{"date":"2025-08-08","current":-1.264689,"twenty":-1.653065,"median":-1.078436,"eighty":-0.763848,"marketCap":124514927},{"date":"2025-08-15","current":-0.856509,"twenty":-1.647396,"median":-1.078154,"eighty":-0.763848,"marketCap":84327569},{"date":"2025-08-22","current":-1.121393,"twenty":-1.645979,"median":-1.079178,"eighty":-0.764222,"marketCap":116609217},{"date":"2025-08-29","current":-1.001018,"twenty":-1.640121,"median":-1.081279,"eighty":-0.765742,"marketCap":104091844},{"date":"2025-09-05","current":-1.127729,"twenty":-1.639362,"median":-1.081279,"eighty":-0.76584,"marketCap":117268026},{"date":"2025-09-08","current":-1.235433,"twenty":-1.639198,"median":-1.08338,"eighty":-0.765906,"marketCap":128467782}],"updateTime":1757434432013},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IOBT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2566668562","title":"IO Biotech Inc : Jefferies Cuts Target Price to $4 From $8","url":"https://stock-news.laohu8.com/highlight/detail?id=2566668562","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566668562?lang=en_us&edition=fundamental","pubTime":"2025-09-09 12:20","pubTimestamp":1757391646,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nFWN3UV1AR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IOBT"],"gpt_icon":0},{"id":"2564523374","title":"IO Biotech Announces Participation in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2564523374","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564523374?lang=en_us&edition=fundamental","pubTime":"2025-09-04 20:05","pubTimestamp":1756987500,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept.  04, 2025  (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, ann","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/04/3144481/0/en/IO-Biotech-Announces-Participation-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2271345857.HKD","SGXZ57979304.SGD","LU1929549753.HKD","LU1116320901.HKD","IE000M9KFDE8.USD","LU2112291526.USD","LU1037948541.HKD","LU1548497426.USD","LU0965509283.SGD","LU1934455194.USD","LU0359201612.USD","LU0203345920.USD","LU0985320562.USD","LU1668664300.SGD","LU0098860793.USD","LU1244550494.USD","BK4571","LU2468319806.SGD","IE00BBT3K403.USD","01698","SG9999002224.SGD","BK4108","LU2133065610.SGD","LU0225283273.USD","LU0359202008.SGD","IOBT","IE00BLSP4239.USD","IE00BKVL7J92.USD","LU1974910355.USD","LU1066051811.HKD","BK4531","LU0238689110.USD","LU1430594728.SGD","LU2023250504.SGD","BK4552","LU1066051498.USD","IE00B12V2V27.USD","LU0795875169.SGD","BK4585","LU2357305700.SGD","LU1585245621.USD","LU2039709279.SGD","SG9999001176.USD","IE00B2B36J28.USD","LU0208291251.USD","BK4504","LU0795875086.SGD","MRK","TME","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2559962952","title":"IO Biotech Inc reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2559962952","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559962952?lang=en_us&edition=fundamental","pubTime":"2025-08-15 05:05","pubTimestamp":1755205544,"startTime":"0","endTime":"0","summary":"IO Biotech Inc reports results for the quarter ended June 30 - Earnings SummaryIO Biotech Inc IOBT.OQ reported a quarterly adjusted loss of 35 cents per share for the quarter ended June 30, lower than","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nL8N3U61TH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IOBT"],"gpt_icon":0},{"id":"2559396412","title":"IO Biotech Q2 EPS $(0.40) Misses $(0.35) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2559396412","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559396412?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:35","pubTimestamp":1755203737,"startTime":"0","endTime":"0","summary":"IO Biotech (NASDAQ:IOBT) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.35) by 13.64 percent. This is a 29.03 percent decrease over losses of $(0.31) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47140116/io-biotech-q2-eps-0-40-misses-0-35-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"IO Biotech Q2 EPS $(0.40) Misses $(0.35) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IOBT"],"gpt_icon":0},{"id":"2559961959","title":"IO Biotech Q2 Pretax Profit USD -26.099 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2559961959","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559961959?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:05","pubTimestamp":1755201902,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nPLX099339:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IOBT"],"gpt_icon":0},{"id":"2559961798","title":"IO Biotech Inc - Expects That Co Will Have Sufficient Cash to Run Company Into Q1 of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2559961798","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559961798?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:05","pubTimestamp":1755201902,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nPLX099339:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IOBT","BK4139"],"gpt_icon":0},{"id":"2559296109","title":"IO Biotech Reports Second Quarter 2025 Financial Results and Provides Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2559296109","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559296109?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:05","pubTimestamp":1755201900,"startTime":"0","endTime":"0","summary":"Announced clinical improvement in progression free survival observed in pivotal Phase 3 Trial of Cylembio plus KEYTRUDA (pembrolizumab) for the treatment of first-line advanced melanoma, but statistic","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/14/3133859/0/en/IO-Biotech-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Business-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","MRK","01698","IE00BZ1G4Q59.USD","LU0122379950.USD","LU2361044949.HKD","LU1548497426.USD","LU1035773651.USD","LU1061106388.HKD","BK4534","LU1066051811.HKD","LU1162221912.USD","LU0070302665.USD","BK4585","IE000M9KFDE8.USD","LU0211331839.USD","IE00BSNM7G36.USD","LU0058720904.USD","LU1732800096.USD","LU1732799900.SGD","SG9999014559.SGD","BK4195","LU0098860793.USD","LU0234572021.USD","PFS","BK4127","LU0912757837.SGD","LU2023250504.SGD","BK4565","LU0208291251.USD","LU1929549753.HKD","LU0266013472.USD","LU1989772923.USD","SG9999015358.SGD","LU1244550577.SGD","LU1720051017.SGD","LU2028103732.USD","BK4139","LU0234570918.USD","LU1074936037.SGD","IOBT","LU2324357040.USD","LU1244550221.USD","LU1917777945.USD","LU1069347547.HKD","LU2133065610.SGD","IE0002141913.USD","LU0265550359.USD","IE00BYTNYN87.SGD"],"gpt_icon":1},{"id":"2558564299","title":"IO Biotech Inc  expected to post a loss of 36 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2558564299","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558564299?lang=en_us&edition=fundamental","pubTime":"2025-08-12 20:42","pubTimestamp":1755002526,"startTime":"0","endTime":"0","summary":"IO Biotech Inc  expected to post a loss of36cents a share - Earnings Preview IO Biotech Inc IOBT.OQ IOBT.O is expected to  show no change in quarterly revenue when it reports  results on August 14 (es","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nL8N3U40VE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IOBT"],"gpt_icon":0},{"id":"2558598662","title":"BUZZ-U.S. STOCKS ON THE MOVE-Elf Beauty, Intel, Archer Aviation","url":"https://stock-news.laohu8.com/highlight/detail?id=2558598662","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558598662?lang=en_us&edition=fundamental","pubTime":"2025-08-12 01:43","pubTimestamp":1754934201,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Elf Beauty, Intel, Archer AviationEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250811:nL6N3U30A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLRY","NVDX","OMI","NVD","LYFT","TZUP","NEM","DOCN","ALTS","SNVD.UK","DUK","IE00B3M56506.USD","TBBK","NVIW.SI","NVDS","INTC","LU1621768206.USD","NVD3.UK","NVD2.UK","WW","CEG","ELF","RUM","LU1623119135.USD","3NVD.UK","TKO","AVTR","CCIR","NVDD","IMXI","PSKY","ACHR","GNRC","NVDY","CAPR","IOBT","NVDS.UK","MLNK","APA","SCCO","2NVD.UK","EOG","NVDU","KYIV"],"gpt_icon":1},{"id":"2558669607","title":"BUZZ-IO Biotech drops after cancer vaccine narrowly misses main goal of late-stage study","url":"https://stock-news.laohu8.com/highlight/detail?id=2558669607","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558669607?lang=en_us&edition=fundamental","pubTime":"2025-08-11 22:52","pubTimestamp":1754923935,"startTime":"0","endTime":"0","summary":"BUZZ-IO Biotech drops after cancer vaccine narrowly misses main goal of late-stage studyUpdates** Shares of biotech firm IO Biotech IOBT.O fall 19.9% to $1.45 after surging over 50% in premarket trading** Company says patients on its experimental cancer vaccine, in combination with Merck's MRK.N Keytruda, showed improvement in a late-stage study goal, but narrowly missed the main goal as the results did not show statistical significance** Co says the study data showed that patients on the combination treatment experienced slower disease progression, with a hazard ratio of 0.77; However, the result was not statistically significant, as the p-value of 0.056 was slightly above the threshold of 0.045. ** Despite the miss, the vaccine led to improvement in progression-free survival in patients with advanced skin cancer in late-stage study. ** Company plans to meet with the U.S. FDA this fall to discuss the data and next steps for a potential regulatory submission** Including session moves, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250811:nL4N3U30YA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266013472.USD","IE00BBT3K403.USD","LU0965509283.SGD","SG9999002232.USD","BK4585","MRK","LU0238689110.USD","LU0006306889.USD","LU0122379950.USD","LU0098860793.USD","LU1934455277.USD","IE00BLSP4239.USD","IE000M9KFDE8.USD","LU2106854487.HKD","LU1037948897.HKD","BK4139","LU2361044865.SGD","SG9999015358.SGD","SGXZ57979304.SGD","LU1116320901.HKD","LU1162221912.USD","BK4588","LU0965509010.AUD","LU2023250504.SGD","LU2468319806.SGD","LU0965509101.SGD","LU1035773651.USD","LU0861579265.USD","BK4533","LU1291159041.SGD","LU1066051498.USD","SG9999001176.USD","LU0208291251.USD","IOBT","LU2361045086.USD","LU0320765646.SGD","IE00B2B36J28.USD","LU1983299246.USD","LU1989772840.SGD","IE00BJT1NW94.SGD","IE00B1BXHZ80.USD","LU1093756325.SGD","LU1974910355.USD","LU1699723380.USD","LU0265550359.USD","LU0058720904.USD","LU2112291526.USD","LU1069347547.HKD","LU1941712264.USD","LU0320765489.SGD"],"gpt_icon":0},{"id":"2558766859","title":"IO Biotech Shares up 12.2% at $2.03 Premarket in Volatile Trading Shortly After Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2558766859","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558766859?lang=en_us&edition=fundamental","pubTime":"2025-08-11 20:36","pubTimestamp":1754915789,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250811:nFWN3U313W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IOBT"],"gpt_icon":0},{"id":"2558505246","title":"IO Biotech Shares up 56.9%  Premarket After Co Reports Late-Stage Data for Therapeutic Cancer Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2558505246","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558505246?lang=en_us&edition=fundamental","pubTime":"2025-08-11 20:09","pubTimestamp":1754914169,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250811:nFWN3U316G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IOBT"],"gpt_icon":0},{"id":"2558553650","title":"IO Biotech Announces Promising Results in Phase 3 Trial of Cylembio Plus KEYTRUDA for Advanced Melanoma, Plans FDA Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2558553650","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558553650?lang=en_us&edition=fundamental","pubTime":"2025-08-11 20:02","pubTimestamp":1754913733,"startTime":"0","endTime":"0","summary":"IO Biotech Inc. has announced clinical improvement in progression-free survival demonstrated in a pivotal Phase 3 trial of Cylembio combined with KEYTRUDA  for the treatment of first-line advanced melanoma. The results showed that patients treated with the combination therapy achieved an improvement in progression-free survival compared to those treated with pembrolizumab monotherapy, with a hazard ratio of 0.77 and a median progression-free survival of 19.4 months versus 11.0 months. However, the study's primary endpoint narrowly missed the statistical significance threshold. IO Biotech plans to discuss the data with the United States Food and Drug Administration this fall to determine next steps for submission of a Biologics License Application. The company also plans to present more detailed results from the IOB-013 study at a future medical meeting.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250811:nNDL7Rz824:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IOBT"],"gpt_icon":0},{"id":"2558657257","title":"IO Biotech Inc - Cylembio Plus Keytruda Well Tolerated With No New Safety Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=2558657257","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558657257?lang=en_us&edition=fundamental","pubTime":"2025-08-11 20:00","pubTimestamp":1754913602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250811:nTUAFMKBF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IOBT"],"gpt_icon":0},{"id":"2558572866","title":"IO Biotech Inc - Plans FDA Meeting This Fall for Regulatory Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2558572866","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558572866?lang=en_us&edition=fundamental","pubTime":"2025-08-11 20:00","pubTimestamp":1754913602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250811:nTUAFMKBF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IOBT"],"gpt_icon":0},{"id":"2558448657","title":"IO Biotech Announces Clinical Improvement in Progression Free Survival Demonstrated in Pivotal Phase 3 Trial of Cylembio® Plus Keytruda® (Pembrolizumab) for the Treatment of First-Line Advanced Melanoma, but Statistical Significance Narrowly Missed","url":"https://stock-news.laohu8.com/highlight/detail?id=2558448657","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558448657?lang=en_us&edition=fundamental","pubTime":"2025-08-11 20:00","pubTimestamp":1754913602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250811:nTUAFMKBF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IOBT"],"gpt_icon":0},{"id":"2558892526","title":"IO Biotech to Announce Topline Results of Pivotal Phase 3 Trial of Cylembio® in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2558892526","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558892526?lang=en_us&edition=fundamental","pubTime":"2025-08-10 20:00","pubTimestamp":1754827200,"startTime":"0","endTime":"0","summary":"NEW YORK, Aug.  10, 2025  (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company, today announced the company will hold a conference call and webcast on Monday, Augu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/10/3130545/0/en/IO-Biotech-to-Announce-Topline-Results-of-Pivotal-Phase-3-Trial-of-Cylembio-in-Combination-with-KEYTRUDA-pembrolizumab-as-a-First-Line-Treatment-for-Patients-with-Advanced-Melanoma.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z4B17.USD","MRK","IE00B66KJ199.SGD","BK4157","IE0031619046.USD","IE00B7SZL793.SGD","IOBT","AEIS","BK4139"],"gpt_icon":0},{"id":"2557960528","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2557960528","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557960528?lang=en_us&edition=fundamental","pubTime":"2025-08-08 18:00","pubTimestamp":1754647200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·CPI Card Grp                                    2Q       .65   7:00 AM. ·Plains All Amr Ppln                              2Q       .32       BMO","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGC","DEC","LINC","SBS","EMA","ASIC","SHC","IMXI","PAR","LAR","PNNT","MAC","IHRT","AMCX","FLNC","TARA","UAA","PMTS","PFLT","LEGN","QRHC","BLDP","HRTX","BW","HROW","PAL","RAL","SLVM","ARQ","BLTE","WEN","RPAY","CE","ATLC","DCBO","INR","ESNT","ARCT","ATXS","DDD","GTN.A","AQST","LAMR","KYMR","JSPR","IOBT","GRDN"],"gpt_icon":1},{"id":"2555380044","title":"IO Biotech Inc  expected to post a loss of 36 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2555380044","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555380044?lang=en_us&edition=fundamental","pubTime":"2025-07-30 20:42","pubTimestamp":1753879325,"startTime":"0","endTime":"0","summary":"IO Biotech Inc  expected to post a loss of36cents a share - Earnings Preview IO Biotech Inc IOBT.OQ IOBT.O is expected to  show no change in quarterly revenue when it reports  results on August 1 (est","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250730:nL8N3TR1G5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IOBT"],"gpt_icon":0},{"id":"2554736880","title":"BRIEF-IO Biotech Files Prospectus Relates To Resale, From Time To Time For Offering Of Up To 4.2 Million Shares By Selling Stockholders- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2554736880","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554736880?lang=en_us&edition=fundamental","pubTime":"2025-07-25 06:31","pubTimestamp":1753396268,"startTime":"0","endTime":"0","summary":"BRIEF-IO Biotech Files Prospectus Relates To Resale, From Time To Time For Offering Of Up To 4.2 Million Shares By Selling Stockholders- SEC FilingJuly 24  - SEC Filing:IO BIOTECH FILES PROSPECTUS RELATES TO RESALE, FROM TIME TO TIME FOR OFFERING OF UP TO 4.2 MILLION SHARES BY SELLING STOCKHOLDERS- SEC FILINGSource text: [ID:n0001193125-25-164495]Further company coverage: IOBT.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nFWN3TL1J7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IOBT","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":31,"code":"91000000","status":"200"}]}}